Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 248 entries
View as:

A Trial to Evaluate Efficacy of Reinduction With Nadofaragene Firadenovec in Subjects With CIS ± High-grade Ta/T1 and no Complete Response to First Nadofaragene Firadenovec Dose.

Phase: N/A Priority: Normal
NCT ID: NCT06390111 Org: User:
Start: 06/17/24 End: 07/31/26 Due: 07/31/27

Study Investigating the Long-Term Safety and Tolerability of Repeated Doses of Degarelix in Prostate Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00245466 Org: User:
Start: 10/31/01 End: 03/31/06 Due: 03/31/07

REgistry of MisOprostol 200 µg Vaginal dElivery System

Phase: N/A Priority: Normal
NCT ID: NCT02242214 Org: User:
Start: 09/30/14 End: 08/31/15 Due: 08/31/16

Effect of Oxytocin Antagonist on Reduction of Uterine Contractions

Phase: N/A Priority: Normal
NCT ID: NCT01043120 Org: User:
Start: 02/28/10 End: 12/31/10 Due: 12/31/11

Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 2

Phase: N/A Priority: Normal
NCT ID: NCT01956123 Org: User:
Start: 03/26/14 End: 01/03/17 Due: 01/03/18

Study to Assess the Design of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT04503707 Org: User:
Start: 06/17/20 End: 10/31/21 Due: 10/31/22

A Trial to Compare Efficacy and Safety of Follitropin Delta Versus Placebo (Inactive Treatment) in the Treatment of Men With Idiopathic Infertility (Unexplained Reduction of Semen Quality) (ADAM)

Phase: N/A Priority: Normal
NCT ID: NCT05403476 Org: User:
Start: 08/16/22 End: 10/23/24 Due: 10/23/25

A Randomised Trial Comparing the Ovarian Response of a Starting Dose of Either 10 μg or 15 μg Follitropin Delta (FE 999049) to a Starting Dose of Either 150 IU or 225 IU Follitropin Alfa (GONAL-F) in Conventional Regimens in China

Phase: N/A Priority: Normal
NCT ID: NCT06173869 Org: User:
Start: 03/29/24 End: 05/31/25 Due: 05/31/26

Efficacy and Safety of Degarelix One Month Dosing Regimen in Korean Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01071915 Org: User:
Start: 03/31/10 End: 11/30/11 Due: 11/30/12

Efficacy and Safety of Desmopressin (Nocturin®) 0.1 mg Tablets in Treatment of Nocturia in Participants With Benign Prostate Syndrome (BPS)

Phase: N/A Priority: Normal
NCT ID: NCT00902265 Org: User:
Start: 02/28/09 End: 03/31/10 Due: 03/31/11

Adipocyte Function and Somtropin Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT01351818 Org: User:
Start: 05/31/05 End: 03/31/08 Due: 03/31/09

Retrospective Data Analysis in Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01363427 Org: User:
Start: 03/31/07 End: 07/31/10 Due: 07/31/11

Selepressin Evaluation Programme for Sepsis-Induced Shock - Adaptive Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT02508649 Org: User:
Start: 07/31/15 End: 02/26/18 Due: 02/26/19

Evaluation of Efficacy and Safety of Highly Purified Urofollitropin for Ovulation Induction in Chinese Females

Phase: N/A Priority: Normal
NCT ID: NCT01923194 Org: User:
Start: 10/31/13 End: 08/31/15 Due: 08/31/16

MENOPUR® in a Gonadotropin-Releasing Hormone (GnRH) Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population

Phase: N/A Priority: Normal
NCT ID: NCT02554279 Org: User:
Start: 08/31/15 End: 02/02/17 Due: 02/02/18

A Trial of Degarelix in Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00946920 Org: User:
Start: 06/30/09 End: 03/31/11 Due: 03/31/12

A Study of Minirin Melt in Patients With Nocturia

Phase: N/A Priority: Normal
NCT ID: NCT01222598 Org: User:
Start: 09/30/08 End: 03/31/11 Due: 03/31/12

Investigation of KLYX in Patients With Constipation

Phase: N/A Priority: Normal
NCT ID: NCT01335386 Org: User:
Start: 04/30/10 End: 07/31/10 Due: 07/31/11

Semapimod for Treatment of Moderate to Severe Crohn's Disease 1 or 3 Days' Treatment Versus Placebo

Phase: N/A Priority: Normal
NCT ID: NCT00739986 Org: User:
Start: 10/31/02 End: 08/31/04 Due: 08/31/05

An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG

Phase: N/A Priority: Normal
NCT ID: NCT00250250 Org: User:
Start: 10/31/05 End: 08/31/06 Due: 08/31/07

A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT06260267 Org: User:
Start: 03/12/24 End: 01/15/26 Due: 01/15/27

Study Assessing CLENPIQ As Bowel Preparation for Pediatric Colonoscopy

Phase: N/A Priority: Normal
NCT ID: NCT04113382 Org: User:
Start: 06/23/22 End: 03/31/26 Due: 03/31/27

Explorative Study of Degarelix for Treatment of Benign Prostatic Hyperplasia.

Phase: N/A Priority: Normal
NCT ID: NCT00527488 Org: User:
Start: 10/31/07 End: 05/31/09 Due: 05/31/10

A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00116779 Org: User:
Start: 02/29/04 End: 08/31/05 Due: 08/31/06

A Safety Study in Patients With Advanced Prostate Cancer Treated With FIRMAGON

Phase: N/A Priority: Normal
NCT ID: NCT01234350 Org: User:
Start: 01/31/11 End: 03/27/18 Due: 03/27/19